Sustained efficacy of dupilumab in paediatric patients with moderate-to-severe atopic dermatitis over 1 year.

Siegfried EC, Baselga E, de Graaf M, Simpson EL, Boguniewicz M, Flohr C, Eichenfield LF, Paller AS, Ramien M, Gao XH, Ahn J, Capozza K, Ma Y, Bates L, Rossi AB

Open source

DOI
10.1093/bjd/ljag261
Published
2026 Sep 18
Container
The British journal of dermatology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/bjd/ljag261,
  title = {Sustained efficacy of dupilumab in paediatric patients with moderate-to-severe atopic dermatitis over 1 year.},
  author = {Siegfried EC and Baselga E and de Graaf M and Simpson EL and Boguniewicz M and Flohr C and Eichenfield LF and Paller AS and Ramien M and Gao XH and Ahn J and Capozza K and Ma Y and Bates L and Rossi AB},
  year = {2026},
  journal = {The British journal of dermatology},
  doi = {10.1093/bjd/ljag261},
  url = {https://doi.org/10.1093/bjd/ljag261}
}

RIS

TY  - JOUR
TI  - Sustained efficacy of dupilumab in paediatric patients with moderate-to-severe atopic dermatitis over 1 year.
AU  - Siegfried EC
AU  - Baselga E
AU  - de Graaf M
AU  - Simpson EL
AU  - Boguniewicz M
AU  - Flohr C
AU  - Eichenfield LF
AU  - Paller AS
AU  - Ramien M
AU  - Gao XH
AU  - Ahn J
AU  - Capozza K
AU  - Ma Y
AU  - Bates L
AU  - Rossi AB
PY  - 2026
JO  - The British journal of dermatology
DO  - 10.1093/bjd/ljag261
UR  - https://doi.org/10.1093/bjd/ljag261
ER  - 

APA

EC, S., E, B., M, D. G., EL, S., M, B., C, F., LF, E., AS, P., M, R., XH, G., J, A., K, C., Y, M., L, B., & AB, R. (2026). Sustained efficacy of dupilumab in paediatric patients with moderate-to-severe atopic dermatitis over 1 year.. The British journal of dermatology. https://doi.org/10.1093/bjd/ljag261

Source records